The future of targeting NQO1 as a potential therapeutic intervention needs a deeper understanding of the complex mechanisms regulating the action of the Nrf2-NQO1 signaling pathway in the development of cerebrovascular diseases. This evidence concerns the gene NQO1 and cerebrovascular disorder.